Trial NCT05126966

View at ClinicalTrials.gov 
Org. Study IDs: MR42410
Secondary IDs: 2021-003226-71

Last trial update was posted on 2024-01-18

MeSH Interventions

Aflibercept Ranibizumab

MeSH Conditions

Macular Degeneration Wet Macular Degeneration

Other Conditions

Neovascular Age-Related Macular Degeneration

Stopping Reasons

Roche/Genentech has initiated an immediate pause of all new PDS implantations because the implants from commercial supply in the clinical studies did not meet the filed specifications for the intended use

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID